Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma.
- DOI
- 10.1002/hon.3247
- Published
- 2024 Jan
- Container
- Hematological oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/hon.3247,
title = {Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma.},
author = {Picardi M and Giordano C and Pugliese N and Mascolo M and Varricchio S and Troncone G and Vigliar E and Bellavicine C and Lamagna M and Lisi D and Vincenzi A and Pane F},
year = {2024},
journal = {Hematological oncology},
doi = {10.1002/hon.3247},
url = {https://doi.org/10.1002/hon.3247}
}RIS
TY - JOUR TI - Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma. AU - Picardi M AU - Giordano C AU - Pugliese N AU - Mascolo M AU - Varricchio S AU - Troncone G AU - Vigliar E AU - Bellavicine C AU - Lamagna M AU - Lisi D AU - Vincenzi A AU - Pane F PY - 2024 JO - Hematological oncology DO - 10.1002/hon.3247 UR - https://doi.org/10.1002/hon.3247 ER -
APA
M, P., C, G., N, P., M, M., S, V., G, T., E, V., C, B., M, L., D, L., A, V., & F, P. (2024). Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma.. Hematological oncology. https://doi.org/10.1002/hon.3247
Source records
- pubmed · retrieved 2026-09-25T00:45:00.951Z